ARCHIVES

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

This article is from The Cancer Letter archive.

Vol. 25 No. 47 | December 10, 1999

Download PDF Visit The Full Archive

Related Articles

Advisors approve NCI’s revised plan for $104-million proteomics research program.

July 8, 2005

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

CIDAC Bids Not Limited To Cancer Research Centers

January 17, 1975

Bills in House, Senate, would give FDA authority over tobacco products.

June 4, 2004

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

AIDs Concepts Totaling $13 Million Approved By DCT Board; Will Be Funded By Special Appropriations

October 11, 1985